Milicevic Sephton Selena, Aigbirhio Franklin I
Molecular Imaging Chemistry Laboratory, Wolfson Brain Imaging Centre, Department of Clinical Neurosciences, University of Cambridge , Box 65, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, U.K.
ACS Med Chem Lett. 2016 Apr 12;7(6):647-51. doi: 10.1021/acsmedchemlett.6b00093. eCollection 2016 Jun 9.
In order to address the limitations associated with the present range of PET radiotracers used for imaging protein synthesis in vivo we have synthesized a candidate PET radiotracer based on Puromycin (3, PURO), a protein synthesis inhibitor. The desmethylPURO 9 precursor for radiolabeling with carbon-11 radioisotope was synthesized in two steps employing EDC/HOBt amide coupling in overall 76% yield. Optimal conditions for radiolabeling were then established via methylation/deprotection sequence. Under these conditions as determined by NMR analysis 9 showed partial stability (ca. 80%) under acidic conditions. Limited evidence of stereochemical stability of 3 was also found. The radiolabeling of intermediate [(11)C]12 was accomplished with up to 57% conversion from [(11)C]iodomethane. An automated method was then developed for high radioactivity radiosynthesis to produce [(11)C]3 ([(11)C]PURO) in 16 ± 6% (n = 3) decay corrected radiochemical yields.
为了解决目前用于体内蛋白质合成成像的正电子发射断层显像(PET)放射性示踪剂系列所存在的局限性,我们基于蛋白质合成抑制剂嘌呤霉素(3,PURO)合成了一种候选PET放射性示踪剂。用于用碳-11放射性同位素进行放射性标记的去甲基PURO 9前体通过两步法合成,采用EDC/HOBt酰胺偶联反应,总产率为76%。然后通过甲基化/脱保护序列确定了放射性标记的最佳条件。在这些条件下,经核磁共振分析确定,9在酸性条件下显示出部分稳定性(约80%)。还发现了3的立体化学稳定性的有限证据。中间体[(11)C]12的放射性标记以高达57%的转化率由[(11)C]碘甲烷完成。然后开发了一种用于高放射性放射合成的自动化方法,以16±6%(n = 3)的衰变校正放射化学产率生产[(11)C]3([(11)C]PURO)。